MW 588.7 Da, Purity >98%. Selective autotaxin inhibitor with potential application in idiopathic pulmonary disease (IPF).
View Alternative Names
ATX, ATX X, Autotaxin, Autotaxin t, ENPP2_HUMAN, Ectonucleotide pyrophosphatase/phosphodiesterase 2, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2, Extracellular lysophospholipase D, FLJ26803, LysoPLD, NPP2, PD IALPHA, PDNP2, Phosphodiesterase I alpha, Phosphodiesterase I/nucleotide pyrophosphatase 2, Plasma lysophospholipase D
Product details
This product is manufactured by BioVision, an Abcam company and was previously called B1850 GLPG-1690. B1850-25 is the same size as the 25 mg size of ab285398.
Protect from air and light.
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ENPP2/ATX plays an important role in processes like cell proliferation migration and survival by producing LPA a bioactive lysophospholipid. LPA acts as a signaling molecule by binding to its specific G-protein-coupled receptors. ENPP2 exists as a monomer and does not form a stable part of a larger protein structure. Its enzymatic activity in generating LPA influences various cellular responses and physiologic states.
Pathways
It is evident that ENPP2 is involved in the LPA signaling pathway and metabolic processes related to phospholipids. The LPA signaling pathway in particular links ENPP2 to proteins such as LPAR1 and LPAR2 which bind LPA and initiate downstream effects. ENPP2's enzymatic product LPA further participates in pathways influencing cellular responses like inflammation and angiogenesis.
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com